 rational treatment substanti evid nih consensu develop confer treatment total low-dens lipoprotein ldl cholesterol elev diet necessari drug risk coronari arteri diseas cad nation cholesterol educ program ncep guidelin moderate- borderline-high- high-risk categori cad mani clinic trial benefit antihyperlipidem therapi evid coronari primari prevent trial rise ratio reduct total cholesterol level decreas cad event helsinki heart studi result addit benefit high-dens lipoprotein hdl -cholesterol level dramat reduct ldl total cholesterol program surgic control hyperlipidemia reduct cad event two-third reduct coronari bypass oper angioplasti long-term benefit cholesterol term cardiovascular all-caus mortal coronari drug project multipl risk factor intervent trial major studi angiograph chang result cholesterol lower cholesterol-low atherosclerosi studi cla famili atherosclerosi treatment studi fat cla fat decreas develop new lesion lower rate progress lesion fat evid aggress antihyperlipidem therapi lesion cad patient